Results 201 to 210 of about 26,133 (216)

Cutaneous leishmaniasis in Niger

The American Journal of Tropical Medicine and Hygiene, 1990
This is the first report of cutaneous leishmaniasis in Niger subsequent to the initial finding in 1911 and the report of a second case in 1943. The clinical, histopathological, and epidemiological features of 64 parasitologically confirmed cases are described. Lesions were mostly multiple, situated on exposed areas of skin, but rarely on the face.
M. Develoux, Andre Warter, Harouna Djingarey Mamoudou, Leopold Blanc, Soga Garba, Pierre Ravisse   +5 more
openaire   +3 more sources

Cutaneous leishmaniasis and leprosy

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1978
Eight patients who had concomitant leprosy and leishmaniasis are described. Two patients with lepromatous leprosy had high resistance leishmaniasis, implying that the immune deficiency in lepromatous leprosy is specific to Mycobacterium leprae.
R. StC. Barnetson, A.D.M Bryceson
openaire   +3 more sources

Cutaneous Leishmaniasis in an Infant

Pediatric Dermatology, 1983
Abstract: Cutaneous leishmaniasis (CL) in the United States is unusual. We report an infant who developed CL after returning from an endemic area. A skin biopsy yielded Leishmania organisms within 48 hours. The cutaneous lesions resolved with scarring after several months.
James Longabaugh, Paul W. Orton, Loren E. Golitz, J. Joseph Marr, William L. Weston, Barbara R. Reed   +5 more
openaire   +3 more sources

Diagnosis of cutaneous leishmaniasis

Current Opinion in Infectious Diseases, 2003
The purpose of this review is to discuss some of the most important issues in the clinical and laboratory diagnosis of cutaneous leishmaniasis. The former is based on clinical experience and the latter on the literature published within the last couple of years.
openaire   +3 more sources

Cutaneous leishmaniasis treatment

Travel Medicine and Infectious Disease, 2007
The causative species of cutaneous leishmaniasis determines the clinical features and courses, and treatments. Intralesional or systemic antimonials are the gold standard for the treatment of these diseases. However, as for visceral leishmaniasis, other therapeutic options appear promising.
Philippe Minodier, Philippe Parola
openaire   +3 more sources

Epidemiology of cutaneous leishmaniasis

Clinics in Dermatology, 1999
Leishmaniasis refers to an infection caused by protozoan parasites of the genus Leishmania. Of the three clinical expressions of the disease—cutaneous, visceral, and mucocutaneous—the cutaneous form (CL) is the most abundant. It is important to recognize that CL does not refer to a single disease.
Arieh Ingber, Sidney Klaus, Shoshana Frankenburg   +2 more
openaire   +3 more sources

Cutaneous Leishmaniasis in Mali

Dermatologic Clinics, 2011
While not as common as in other parts of the world, cutaneous leishmaniasis is endemic to countries in Africa, particularly in the north, central, east, and south. Sporadic case reports of cutaneous leishmaniasis in countries spanning West Africa have allowed scientists to propose an endemic belt in sub-Saharan Africa ranging from Senegal to Cameroon ...
Somita Keita, Seydou Doumbia, Carlos Paz, Aisha Sethi   +3 more
openaire   +3 more sources

Cutaneous Leishmaniasis

New England Journal of Medicine, 2020
Alexia P, Knapp, Jonathan D, Alpern
openaire   +2 more sources

Management of cutaneous leishmaniasis

Current Opinion in Infectious Diseases, 2001
There is an urgent need for a safe, effective, easily administered and cheap treatment for cutaneous leishmaniasis. Unfortunately it remains elusive. There have been a number of contributions during the last year, but none will change present day management.
openaire   +3 more sources

Cutaneous Leishmaniasis

JAMA: The Journal of the American Medical Association, 1963
W M, FRASER, R G, FREEMAN, D A, DREYER, J M, KNOX   +3 more
openaire   +2 more sources